Educational use only. Not a substitute for clinical judgment. Always verify independently.
Steroid Taper Planner
Generate a day-by-day prednisone taper schedule with HPA-axis-aware slow zone below 10 mg.
mg
days
mg
Pace
| Day | Dose | For |
|---|---|---|
| Day 0 | 60 mg | 7 d |
| Day 7 | 50 mg | 7 d |
| Day 14 | 40 mg | 7 d |
| Day 21 | 35 mg | 7 d |
| Day 28 | 30 mg | 7 d |
| Day 35 | 25 mg | 7 d |
| Day 42 | 20 mg | 7 d |
| Day 49 | 17.5 mg | 7 d |
| Day 56 | 15 mg | 7 d |
| Day 63 | 12.5 mg | 7 d |
| Day 70 | 10 mg | 7 d |
| Day 77 | 9 mg | 14 d |
| Day 91 | 8 mg | 14 d |
| Day 105 | 7 mg | 14 d |
| Day 119 | 6 mg | 14 d |
| Day 133 | 5 mg | 14 d |
| Day 147 | 4.5 mg | 14 d |
| Day 161 | 4 mg | 14 d |
| Day 175 | 3.5 mg | 14 d |
| Day 189 | 3 mg | 14 d |
| Day 203 | 2.5 mg | 14 d |
| Day 217 | 2 mg | 14 d |
| Day 231 | 1.5 mg | 14 d |
| Day 245 | 1 mg | 14 d |
| Day 259 | 0.5 mg | 14 d |
| Day 273 | 0 mg | — |
Total taper
273days
Steps
25
HPA-axis suppression likely
Long-duration high-dose steroid therapy suppresses endogenous cortisol production. Below 10 mg/day, slow the taper considerably. Consider an 8 AM cortisol or ACTH stimulation test before complete discontinuation; persistent suppression may require physiologic replacement (5 mg) until recovery.
Long-duration high-dose therapy (30 days, current 60 mg) — HPA-axis suppression is likely. Slow the taper below 10 mg, and consider an 8 AM cortisol or ACTH stim test before complete discontinuation.
Disease-specific considerations
- Asthma / COPD exacerbation: short bursts (5–7 days at 40–60 mg) usually do not require tapering.
- Inflammatory disease flare (PMR, GCA, RA, vasculitis): tapers are disease-activity-driven, not just dose-driven — restart higher dose if symptoms recur.
- Adrenal insufficiency: tapering ends at physiologic replacement (~5 mg), not zero, until HPA recovery is documented.
References
Updated 2026-04-28Report an error